Donate

News

Categories
Sign up to our newsletter

News

Image of entrance sign to PA Hospital
CAR T-cell therapy now available at Princess Alexandra Hospital, Brisbane
published June 3, 2025
Great news for patients in QLD with another hospital accredited to provide CAR T-cell therapy for eligible pat
Read more
Tracking Long-term Effects of Cancer Treatment
published April 28, 2025
Roughly 800 people are diagnosed with Hodgkin Lymphoma each year in Australia, and both adults and children ca
Read more
CAR T-Cell Therapy – Why Some Australians Still Miss Out
published April 14, 2025
Chimeric Antigen Receptor T-cell Therapy – better known as  CAR T-cell therapy is a treatment for people with
Read more
CLL/SLL, MCL, MZL, WM – BRUKINSA® (Zanubrutinib) updates
published April 7, 2025
The TGA has approved zanubrutinib for more people with lymphoma, and some of these are now PBS listed.
Read more
Logo for Juniper biologics
Great news for patients with Mycosis Fungoides
published January 23, 2025
LEDAGA® now PBS listed for patients with limited stage Mycosis Fungoides T-cell lymphoma.
Read more
Lymphoma Australia turns 20 in 2024
published July 23, 2024
We are here to support people affected by lymphoma or CLL.
Read more
CAR T-cell Therapy now available in North Queensland
published July 12, 2024
Gilead welcomes the opening of Australia’s first regional CAR T-cell treatment centre at Townsville Hospital
Read more
Your Life Matters
published November 6, 2023
Are you living (or caring for someone) with Chronic Lymphocytic Leukaemia or Small Lymphocytic Leukaemia? A g
Read more
ALLG: Next generation of better blood cancer treatments
published October 31, 2023
Media Release: Next generation of better blood cancer treatments, building on five decades of research  We
Read more
Losing the locks to help lymphoma
published October 30, 2023
Staff members Immy and Madie admire colleague Do
Read more
Spreading the message this Lymphoma Awareness Month
published September 30, 2023
Challenging time: Guy Dunn and Eva Driver are sp
Read more
LEG-endary status unlocked!
published May 23, 2023
Thank you Lymphoma LEGends!!! During March and April more than 600 pairs of legs hit the pavement, lapped the
Read more
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Newsletter Sign Up

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.